[Sight Diagnostics in Globes] Blood test co Sight Diagnostics raises $28m
Clal Biotechnology Industries Ltd. (TASE: CBI) today announced that Sight Diagnostics, a portfolio company of Anatomy, Clal Biotechnology’s investment fund for medical devices, had raised $28 million. Read more on...
Read More